This patent is part of the huge wall Amgen put around the IP for stem cell factor. This patent specifically encompasses the cells that are transformed with SCF genes in order to generate SCF protein. SCR is the same as kit ligand.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.